Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Founded
2001
25 years
Office countries
1
1 address
Company type
Privately Held
self-reported
Description
BioNet is the only manufacturer of recombinant acellular Pertussis vaccines, produced by using a patented recombinant DNA technology. They contain a genetically-inactivated Pertussis Toxin (PTgen) which induces higher anti-PT immune response as demonstrated in several clinical trials. Two PTgen-containing vaccines are already available in Thailand: a monovalent acellular Pertussis (aP) vaccine and a Tetanus-diphtheria-acellular Pertussis (TdaP) combination vaccine which are used for booster immunization in adolescents and adults including pregnant women.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | TH |
All codes: TH
Addresses
- TH19 Soi Udomsuk 37, Sukhumvit 103 Road, Bangjak; Prakanong, Bangkok 10260Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
FAQ
Where does PTgen have offices?
One address on record, Thailand only. Primary: 19 Soi Udomsuk 37, Sukhumvit 103 Road, Bangjak, Prakanong, Bangkok 10260.
Which companies are listed alongside PTgen?
2 profiles list PTgen as a peer — 42nd percentile in Biotechnology Research. It lists ten peers of its own. Biogenetech Co., Ltd. and BioNet list it back.